The current financial score of Intelligent Bio Solutions Inc is 7.40. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.15M, representing a year-over-year increase of 35.78%, while its net profit experienced a year-over-year increase of 26.46%.
The current valuation score of Intelligent Bio Solutions Inc is 9.01. Its current P/E ratio is -0.15, which is -332.53% below the recent high of 0.36 and -6737.85% above the recent low of -10.55.
The current earnings forecast score of Intelligent Bio Solutions Inc is 10.00. The average price target is 12.00, with a high of 12.00 and a low of 12.00.
The current price momentum score of Intelligent Bio Solutions Inc is 5.33. Currently, the stock price is trading between the resistance level at 2.50 and the support level at 1.45, making it suitable for range-bound swing trading.
The current institutional shareholding score of Intelligent Bio Solutions Inc is 3.00. The latest institutional shareholding proportion is 0.09%, representing a quarter-over-quarter decrease of 99.16%.
The current risk assessment score of Intelligent Bio Solutions Inc is 2.17. The company's beta value is 4.21. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.